Philippines FDA Issues Circular on Guidelines for the Transition Period for Medical Device to the ASEAN Harmonized Technical Requirements
This Circular issued on 9 August 2021 aims to provide guidelines for the transition period of medical devices covered by FC No. …
Philippines FDA Starts Pilot Implementation of eServices Portal System for Drug Products
The Philippines FDA, in its commitment to provide stakeholders with streamlined and improved government services, is developing the FDA eServices …
Philippines FDA Issues Implementation Schedule and Guidelines on Standards for Medical Devices
The Philippines FDA issued Circular no. 2021-002 on 4th January 2021, which contains the implementation schedule of the Administrative Order …
Philippines FDA adopts the WHO Collaborative Registration Procedure (CRP) for the Accelerated Registration of WHO Prequalified Pharmaceutical Products and Vaccines.
This Administrative Order is issued to establish an accelerated review process for prequalified pharmaceutical products and vaccines, through the adoption …
Philippines to Establish Facilitated Registration and Evaluation Pathways for Drugs, including Vaccines and Biologicals
The FDA of the Philippines has established registration pathways for the registration and evaluation of drug products, including vaccines and …
The Philippines Announces the Launch of Verification Portal for Licensed Establishments and Registered Products
The Philippines Food and Drug Administration, in its commitment to provide stakeholders with streamlined and improved government services, has developed …
Philippines issues New Circular on Registration of Human Influenza Vaccines
The Department of Health of the Philippines has recently issued Circular No: 2020-002 on 06 February 2020 pursuant to the …
Pharmacovigilance Requirements Clarified by the FDA of the Philippines
The Department of Health of Republic of Philippines has issued a Circular No. 2020-003 effective on 26 February 2020 to …
Philippines’ executive order on medicine price cap
Philippines’ President Rodrigo Duterte officially signed the executive order which would see a cap set on selected medicines at a …
More News
ASEAN
Australia
Biologics/Biosimilars
Canada
China
Clinical Trials
Cosmetics
eCTD
EU
Global
Health Supplements
Herbal/Traditional Medicines
Hong Kong
India
Indonesia
Japan
Malaysia
Medical Devices
New Zealand
Pharmaceutical Drugs
Philippines
Singapore
South Korea
Sri Lanka
Switzerland
Taiwan
Thailand
United Kingdom
United States
Vietnam